Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Djulbegovic, B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lilford, RJ; Djulbegovic, B
      Declaration of Helsinki should be strengthened - Equipoise is essential principle of human experimentation

      BRITISH MEDICAL JOURNAL
    2. Lilford, RJ; Djulbegovic, B
      Uncertainty about clinical equipoise - Equipoise and uncertainty principleare not mutually exclusive

      BRITISH MEDICAL JOURNAL
    3. Djulbegovic, B; Adams, JR; Lyman, GH; Lacevic, M; Hozo, I; Greenwich, M; Bennett, CL
      Evaluation and appraisal of randomized controlled trials in myeloma

      ANNALS OF ONCOLOGY
    4. Clark, O; Clark, L; Djulbegovic, B
      Is clinical research still too haphazard?

      LANCET
    5. Djulbegovic, B; Clarke, M
      Ethical issues in the reporting of clinical trials

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    6. Djulbegovic, B; Clarke, M
      Scientific and ethical issues in equivalence trials

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    7. Djulbegovic, B; Clarke, M
      Informing patients of uncertainty in clinical trials - Reply

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    8. Djulbegovic, B; Cohen, Y
      The natural history of refractory idiopathic thrombocytopenic purpura

      BLOOD
    9. Djulbegovic, B
      Placebo-controlled trials

      ANNALS OF INTERNAL MEDICINE
    10. Djulbegovic, B; Morris, L; Lyman, GH
      Evidentiary challenges to evidence-based medicine

      JOURNAL OF EVALUATION IN CLINICAL PRACTICE
    11. Knox, KS; Adams, JR; Djulbegovic, B; Stinson, TJ; Tomori, C; Bennett, CL
      Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology

      ANNALS OF ONCOLOGY
    12. Djulbegovic, B; Bennett, CL; Adams, JR; Lyman, GH
      Industry-sponsored research - Reply

      LANCET
    13. Djulbegovic, B; Lacevic, M; Cantor, A; Fields, KK; Bennett, CL; Adams, JR; Kuderer, NM; Lyman, GH
      The uncertainty principle and industry-sponsored research

      LANCET
    14. Djulbegovic, B
      Acquired anaemias and polycythaemia

      LANCET
    15. Cohen, YC; Djulbegovic, B; Shamai-Lubovitz, O; Mozes, B
      The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts

      ARCHIVES OF INTERNAL MEDICINE
    16. Djulbegovic, B; Lyman, GH; Hozo, I
      Talking about treatment

      ANNALS OF INTERNAL MEDICINE
    17. Djulbegovic, B; Hozo, I
      Computer program for the diagnosis and treatment of polycythemia rubra vera (vol 16, pg 83, 1999)

      M D COMPUTING
    18. Djulbegovic, B; Hozo, I
      Computer program for the diagnosis and treatment of polycythemia rubra vera

      M D COMPUTING
    19. Djulbegovic, B; Hozo, I; Schwartz, A; McMasters, KM
      Acceptable regret in medical decision making

      MEDICAL HYPOTHESES
    20. Hozo, I; Djulbegovic, B
      Using the Internet to calculate clinical action thresholds

      COMPUTERS AND BIOMEDICAL RESEARCH
    21. Djulbegovic, B; Loughran, TP; Hornung, CA; Kloecker, G; Efthimiadis, EN; Hadley, TJ; Englert, J; Hoskins, M; Goldsmith, GH
      The quality of medical evidence in hematology-oncology

      AMERICAN JOURNAL OF MEDICINE
    22. HOZO I; DJULBEGOVIC B
      CALCULATING CONFIDENCE-INTERVALS FOR THRESHOLD AND POSTTEST PROBABILITIES

      M.D. computing
    23. DJULBEGOVIC B; HOZO I
      LINKING EVIDENCE-BASED MEDICINE (EBM) TO CLINICAL DECISION-ANALYSIS (CDA)

      Medical decision making
    24. SCHWARTZ A; DJULBEGOVIC B; HOZO I
      TREATMENT THRESHOLDS AND POSTDECISION REGRET

      Medical decision making
    25. DJULBEGOVIC B; HOZO I; NAJMAN A
      THE VALUE OF HEMATOCRIT IN THE DIAGNOSIS OF POLYCYTHEMIA-VERA

      British Journal of Haematology
    26. DJULBEGOVIC B; HOZO I; HIRSH J
      MANAGEMENT OF THROMBOPHILIA - BENEFIT RISK ANALYSIS/

      Blood
    27. TECIMER C; BHUPALAM L; DJULBEGOVIC B
      IS STANDARD HEPARIN SUPERIOR TO LOW-MOLECULAR-WEIGHT HEPARIN IN MALIGNANCY RELATED DEEP-VEIN THROMBOSIS

      Blood
    28. DJULBEGOVIC B; GOLDSMITH G; VAUGHN D; BIRKIMER J; MARASA M; JOSEPH G; HUANG A; HADLEY T
      COMPARISON OF THE QUALITY-OF-LIFE BETWEEN HIV-POSITIVE HEMOPHILIA PATIENTS AND HIV-NEGATIVE HEMOPHILIA PATIENTS

      Haemophilia
    29. DJULBEGOVIC B; MARASA M; PESTO A; KUSHNER GM; HADLEY T; JOSEPH G; GOLDSMITH G
      SAFETY AND EFFICACY OF PURIFIED FACTOR-IX CONCENTRATE AND ANTIFIBRINOLYTIC AGENTS FOR DENTAL EXTRACTIONS IN HEMOPHILIA-B

      American journal of hematology
    30. FLEMING D; GOLDSMITH J; GOLDSMITH G; DJULBEGOVIC B; STEVENS D; CEVERA A; HERZIG R
      DETERMINANTS OF HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS STEM-CELLTRANSPLANTATION (SCT)

      Experimental hematology
    31. DJULBEGOVIC B; DESOKY AH
      EQUATION AND NOMOGRAM FOR CALCULATION OF TESTING AND TREATMENT THRESHOLDS

      Medical decision making
    32. DJULBEGOVIC B; HOZO I; GOLDSMITH G
      INFORMATION CONTENTS OF THE POLYCYTHEMIA-VERA STUDY-GROUP (PVSG) DIAGNOSTIC-CRITERIA

      Blood
    33. DJULBEGOVIC B
      LACK OF PROPHYLACTIC ANTICOAGULANT-THERAPY IS NOT ASSOCIATED WITH CLINICAL THROMBOTIC COMPLICATIONS IN PATIENTS WITH HEMOPHILIA WHO UNDERGOORTHOPEDIC SURGICAL-PROCEDURES

      American journal of hematology
    34. DJULBEGOVIC B
      COST-EFFECTIVENESS (CE) OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX VERSUS PROTHROMBIN COMPLEX CONCENTRATE (PCC) IN THE TREATMENT OF HEMOPHILIA-B PATIENTS UNDERGOING KNEE SURGERY

      Thrombosis and haemostasis
    35. WHITE GC; SHAPIRO AD; KURCZYNSKI EM; KIM HC; BERGMAN GE; BENJAMIN L; BROOKS P; CORNELL NJ; CZAPEK E; DAVIS RT; DIMICHELE D; DJULBEGOVIC B; GILL JC; GOLDSMITH J; GORDON ME; GREEN D; GREENBERG S; GRIBBLE J; HILGARTNER M; HODDER F; HUTTER JJ; JANCO R; KASPER C; KESSLER C; LUSHER J; MARTINOWITZ U; OPENSHAW TH; PHILLIPS M; PITEL P; POTOLSKY A; PRESTON FE; RAUSEN A; SAVIDGE G; SEXAUER C; SHURAFA M; SMITH G; SWEENEY J; TELFORD M; WILDE J; WILSON W
      VARIABILITY OF IN-VIVO RECOVERY OF FACTOR-IX AFTER INFUSION OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATES IN PATIENTS WITH HEMOPHILIA-B

      Thrombosis and haemostasis
    36. DJULBEGOVIC B; HOZO I; ABDOMEROVIC I; HOZO S
      DIAGNOSTIC ENTROPY AS A FUNCTION OF THERAPEUTIC BENEFIT RISK RATIO/

      Medical hypotheses
    37. DJULBEGOVIC B
      CLINICAL PROBLEM-SOLVING - STILL HAZY AFTER ALL THESE YEARS

      The New England journal of medicine
    38. DJULBEGOVIC B; GOLDSMITH G
      BAYESIAN VALIDATION OF POLYCYTHEMIA-VERA STUDY-GROUP CRITERIA FOR DIAGNOSIS OF POLYCYTHEMIA RUBRA VERA

      Blood
    39. OUSEPH R; JOSEPH G; BARKER R; DJULBEGOVIC B; GOLDSMITH G
      FACTOR-V LEIDEN AND RECURRENT ARTERIOVENOUS SHUNT THROMBOSIS IN HEMODIALYSIS-PATIENTS

      Blood
    40. DJULBEGOVIC B; GOLDSMITH GH
      GUIDELINES FOR MANAGEMENT OF HEMOPHILIA-A AND HEMOPHILIA-B

      Blood
    41. DJULBEGOVIC B; HANNAN MM; BERGMAN GE
      CONCOMITANT TREATMENT WITH FACTOR-IX CONCENTRATES AND ANTIFIBRINOLYTICS IN HEMOPHILIA-B

      Acta haematologica
    42. JOSEPH G; SMITH KJ; HADLEY TJ; DJULBEGOVIC B; TROUP GM; OLDFATHER J; BARKER RL
      HLA-DR53 PROTECTS AGAINST THROMBOTIC THROMBOCYTOPENIC PURPURA ADULT HEMOLYTIC-UREMIC SYNDROME

      American journal of hematology
    43. DJULBEGOVIC B; HANNAN M; BERGMAN GE
      IS PROPHYLACTIC ANTICOAGULANT-THERAPY NECESSARY FOR HEMOPHILIA PATIENTS UNDERGOING ORTHOPEDIC SURGICAL-PROCEDURES

      Blood
    44. DJULBEGOVIC B
      AN ESTIMATION OF LIFE EXPECTANCY - THE METHOD IS A MESSAGE

      Medical decision making
    45. DJULBEGOVIC B; KIM HC
      COMPASSIONATE TREATMENT WITH A MONOCLONAL ANTIBODY-PURIFIED FACTOR-IXCONCENTRATE IN HEMOPHILIA-B SURGICAL PATIENTS WHO HAVE EXPERIENCED THROMBOTIC COMPLICATIONS WITH PROTHROMBIN COMPLEX CONCENTRATES

      Blood
    46. JOSEPH G; SMITH KJ; HADLEY T; DJULBEGOVIC B; TROUP GM; BARKER R
      HLA-DR53 PROTECTS AGAINST TTP-HEMOLYTIC UREMIC SYNDROME (TTP HUS)/

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 12:24:32